HealthDay News — Early uptake was rapid for oral semaglutide (Wegovy pill) relative to injectable incretin-based weight ...
HealthDay News — Medical device adverse event reports are frequently incomplete, inaccurate, and delayed, according to a study published online October 14 in The BMJ.
The investigational vaccine targets pathological amyloid-beta to lower brain amyloid in patients with preclinical Alzheimer ...
The new 150mg oral pellet formulation provides a capsule-free prophylactic option for adults and adolescents with hereditary ...
Mean percentage of time that CGM-measured glucose level was in range of 70 to 180mg/dL was 21 percentage points higher with CGM ...
Patients with baseline viral suppression maintained viral suppression, while those without achieved viral suppression by 13 ...
Strong recommendations include distinguishing bothersome from nonbothersome tinnitus, asking about risks for self-harm.
The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.
The FDA has approved the first generic equivalent of Climara Pro, offering a once-weekly transdermal option for managing moderate to severe vasomotor symptoms and preventing postmenopausal ...
HealthDay News — Antipsychotic treatment initiation is associated with rapid increases in hemoglobin A1c (HbA1c) and weight, according to a study published in the November issue of The Lancet ...
Strong recommendations made for semiannual surveillance for HCC, testing and vaccination for hepatitis A and B.
Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results